3-{4-[({5-[(2,4-Dimethylphenoxy)methyl]-1,3,4-thiadiazol-2-yl}carbonyl)amino]phenyl}propanoic acid

ID: ALA4217530

Chembl Id: CHEMBL4217530

PubChem CID: 145973781

Max Phase: Preclinical

Molecular Formula: C21H21N3O4S

Molecular Weight: 411.48

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(OCc2nnc(C(=O)Nc3ccc(CCC(=O)O)cc3)s2)c(C)c1

Standard InChI:  InChI=1S/C21H21N3O4S/c1-13-3-9-17(14(2)11-13)28-12-18-23-24-21(29-18)20(27)22-16-7-4-15(5-8-16)6-10-19(25)26/h3-5,7-9,11H,6,10,12H2,1-2H3,(H,22,27)(H,25,26)

Standard InChI Key:  IRHRGOXWUAKECK-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4217530

    ---

Associated Targets(Human)

FFAR3 Tchem Free fatty acid receptor 3 (304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FFAR1 Tchem Free fatty acid receptor 1 (4763 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FFAR4 Tchem G-protein coupled receptor 120 (2999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FFAR2 Tchem Free fatty acid receptor 2 (545 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 411.48Molecular Weight (Monoisotopic): 411.1253AlogP: 4.00#Rotatable Bonds: 8
Polar Surface Area: 101.41Molecular Species: ACIDHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 3.77CX Basic pKa: CX LogP: 3.97CX LogD: 0.69
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.58Np Likeness Score: -1.49

References

1. Krasavin M, Lukin A, Bakholdina A, Zhurilo N, Onopchenko O, Borysko P, Zozulya S, Moore D, Tikhonova IG..  (2017)  Continued SAR exploration of 1,2,4-thiadiazole-containing scaffolds in the design of free fatty acid receptor 1 (GPR40) agonists.,  140  [PMID:28938138] [10.1016/j.ejmech.2017.09.019]

Source